Get E&O weekly. | Subscribe
Digital health research from Brian Dolan.
Welcome to E&O.
Last week I wrote about how "breakthrough" is "too breakthrough" to secure CMS reimbursement under its latest proposed rule. Plus -- continuing on the "break" theme -- I posted the numbers related to Teladongo merger break-up fees. Finally, I dug into how some think about the regulated and unregulated